Olmesartan Medoxomil 40 Mg

Olmesartan 40mg tablet is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan 40mg tablet belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

This medicine may be taken with or without food. In addition to taking this medicine, treatment for your high blood pressure may include weight control and a change in the foods you eat, especially foods high in sodium (salt). Your doctor will tell you which of these are most important for you.

Protect from moisture or light and store below 30 degrees Celsius (C).

Side effects may include nausea, hyperuricemia, dizziness, and upper respiratory infection.

Evidence has demonstrated fetal abnormalities or risks when used during pregnancy. Evidence has demonstrated harmful infant effects when used during breastfeeding.

Using this medicine while you are pregnant can harm your unborn baby. Dizziness or lightheadedness may occur after the first dose of this medicine, especially if you have been taking a diuretic (water pill). Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy. Check with your doctor right away if you or your child become sick while taking this medicine, especially with severe or continuing nausea, vomiting, or diarrhea. These conditions may cause you to lose too much water, and may lead to low blood pressure. You can also lose water by sweating, so drink plenty of water during exercise or in hot weather. Severe, chronic diarrhea with weight loss may develop months to years after taking this medicine. Tell your doctor right away if you have these symptoms. Ask your doctor before you use medicines, supplements, or salt substitutes that contain potassium.

Product Information: BENICAR HCT(R) oral tablets, olmesartan medoxomil hydrochlorothiazide oral tablets. Daiichi Sankyo, Inc (per FDA), Parsippany, NJ, 2020.

Olmesartan medoxomil, an angiotensin II receptor antagonist (AT(1) subtype), selectively blocks the binding of angiotensin II to AT(1) receptor in vascular smooth muscle, thereby preventing the vasoconstrictor effects of angiotensin II

Cardiovascular Agent